Allez au contenuAllez à la navigation

Au cœur de l’action dans le domaine oncologique

|15 juin 2017
Gros plan d'un micro sur scène
Rédigé par
Candice Bruton

Candice Bruton

Rédigé par
Tenney Loweth

Tenney Loweth

Quiconque travaille dans un domaine lié au cancer sait que l’assemblée générale annuelle de l’American Society of Clinical Oncology (ASCO) est un incontournable pour découvrir les dernières nouvelles sur la recherche de pointe. Chaque année, des dizaines de milliers de personnes se rendent à Chicago pour cet événement de cinq jours, et l’ASCO de cette année n’a pas fait exception – attirant près de 40 000 participants des quatre coins de la planète. En collaboration avec d’autres collègues au Royaume-Uni et sur place à Chicago, l’équipe de communication dans le secteur de la santé du bureau de Toronto de NATIONAL a pris le pouls de toute l’information diffusée durant l’événement pour s’assurer que nos clients soient informés de toutes les annonces pertinentes en temps réel. Candice Bruton et Tenney Loweth partagent leur expérience et expliquent pourquoi la portée et l’ampleur impressionnantes de l’ASCO, ainsi que le rôle qu’a joué la Firme dans le monitorage des informations, ont été une excellente occasion d’en apprendre davantage sur le domaine de l’oncologie. (Le billet est en anglais.)

———

As anyone who works in a cancer-related field will know, the American Society of Clinical Oncology’s annual meeting, ASCO for short, is the place to be for news about cutting-edge research. It is also where former U.S. Vice-President, Joe Biden, gave his famous ‘Cancer Moonshot’ speech in 2016.

Every year, tens of thousands of people descend on Chicago for this 5-day event. This year’s ASCO is no exception – attracting close to 40,000 attendees from all over the world. Most of those in attendance are healthcare professionals, but you’ll also find patient activists and adventurous investors in the mix.

Trending topics included combination immunotherapies and CAR-T cells. The interest in combination immunotherapies was expected, and we think it will only grow when #ASCO18 comes around. As for CAR-T cells, early studies have shown promise. However, at least one outlet has pointed out potential challenges with getting them to patients. Stay tuned to see how these treatment classes mature over the next few years.

From a communications perspective, we are tasked with taking a pulse of the news flow from ASCO to ensure our clients are informed of all relevant announcements in real-time. And when 17,139 Twitter users generate more than 92,000 tweets over the course of what is essentially an extra-long weekend, the team gets a rare opportunity to bond outside of the daily hustle and bustle that is the agency life.

The impressive scope and scale of ASCO and our role in staying updated on all the releases is a great opportunity to learn more about the field of oncology. Researchers and physicians present new and exciting trial results and treatment options, and seeing the reaction (mainly through social media) from reporters and patient groups is an interesting way to see how these changes are made and brought to patients.

Over the course of the weekend, the team diligently monitored traditional and social media announcements and coverage coming out of the conference, providing real-time updates and reports to clients on the ‘big news’ of the day. We also provided off-site support to our clients and colleagues on the ground, developing media/reporter backgrounders for interviews and conducting research for the on-site team. With music keeping energy levels high and lots of snacks to sustain us in the office, the team had a great time.

——— Candice Bruton était anciennement directrice au Cabinet de relations publiques NATIONAL

——— Tenney Loweth était directrice adjointe, Santé au Cabinet de relations publiques NATIONAL